Author
Ramachandran Venkitaraman
Also Known As
Lubna Bhatt, R Venkitaraman, R. Venkitaraman, Ramachandran Venkitaraman, Susan Upson, Umesh Velu
76
Publications
2.1K
Citations
27
H-Index
49
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 10 | 11 | 342 |
2 | Health Sciences | 7 | 7 | 210 |
3 | Molecular Medicine | 1 | 1 | 11 |
4 | Neurology | 1 | 1 | 43 |
5 | Obstetrics | 1 | 1 | 38 |
Ramachandran Venkitaraman
×
38
Publications
1.7K
Citations
24
H-Index
| Year | Citations | |
|---|---|---|
2020 | 220 | |
2020 | 159 | |
Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive, HER2-negative breast cancer (FAKTION): overall survival, updated progression-free survival, and expanded biomarker analysis from a randomised, phase 2 trial | 2022 | 136 |
2014 | 93 | |
2007 | 79 | |
2006 | 68 | |
2018 | 66 | |
2022 | 57 | |
2007 | 55 | |
2007 | 43 |
Page 1
Page 1